By
Mauritania is not one of the largest O&P markets in the IMEA universe, but it is a market that deserves more attention than it usually gets.
With a population of 5.0 million in 2023, health expenditure of 4.12% of GDP in 2021, and lower-middle-income status, Mauritania presents a smaller-scale but meaningful rehabilitation opportunity shaped by service gaps, chronic disease growth, and the practical need for affordable assistive solutions rather than premium-only technologies.
For prosthetics, orthotics, and rehabilitation providers, Mauritania’s importance lies less in market scale and more in basic access and service development. WHO’s broader framing on rehabilitation and assistive technology is especially relevant here: rehabilitation is an essential health service, while assistive products such as prostheses, orthoses, wheelchairs, and walking aids help maintain function and reduce the impact of disability and chronic disease. In countries where specialist capacity is limited, the unmet need for these services is often larger than the visible installed market.
Why Mauritania matters for prosthetics and orthotics
The clearest O&P growth signal in Mauritania is diabetes and limb-preservation need. The IDF Diabetes Atlas estimates that Mauritania had around 95,700 adults aged 20–79 living with diabetes in 2024, with an age-standardised prevalence of 5.2%. More strikingly, the IDF estimates that 78.7% of people with diabetes in Mauritania remain undiagnosed. That implies a large pool of patients who may present late, often after complications have already advanced.
For the O&P sector, that matters because late-detected diabetes typically increases the need for screening, offloading, diabetic footwear, custom insoles, walking aids, and eventually post-amputation rehabilitation. WHO explicitly notes that assistive technology can help prevent or reduce secondary complications, including lower-limb amputation in people with diabetes. In Mauritania, where diagnosis gaps appear very high, the case for early orthotic and assistive intervention is particularly strong.
Rehabilitation demand drivers
Mauritania’s O&P relevance is not limited to diabetes. WHO’s country overview shows that Mauritania faces a broader health burden that includes road traffic deaths, hypertension, adult obesity, and noncommunicable disease risk, all of which can translate into rehabilitation demand over time. At the same time, the WHO country page warns that mortality and cause-of-death estimates for Mauritania should be interpreted cautiously because death registration data remain incomplete. That caveat is important, but it does not change the overall direction of travel: Mauritania is a country where chronic disease and injury are likely to generate increasing need for practical rehabilitation and mobility support.
For IMEA CPO readers, that usually points toward demand in areas such as:
- diabetic foot care and protective footwear
- basic and intermediate orthoses
- mobility aids and walking support
- selected prosthetic services
- rehabilitation-linked assistive products
That is partly an inference rather than a direct national procurement forecast, but it is a grounded one based on WHO’s assistive technology framework and Mauritania’s disease profile.
A market shaped by access more than by premium demand
Mauritania is best understood as a practical solutions market, not a premium component-led market. The strongest commercial opportunities are likely to sit in cost-effective products and service models that solve everyday mobility and function problems rather than in high-end imported technologies alone. The World Bank’s 2025 support programme for Mauritania emphasised the need to improve human capital, health service quality, social protection, and resilience of vulnerable populations, which is consistent with a system still building core service capacity.
That has direct implications for O&P strategy. In a market like Mauritania, success is more likely to come from:
- affordable, durable orthotic products
- diabetic foot pathways
- assistive technology access
- clinician education
- simple but scalable rehabilitation models
rather than from a narrow focus on premium products with limited reimbursement fit. This is an inference from the country’s income level, health spending profile, and wider development priorities.
Key opportunities for IMEA CPO readers
Diabetic foot and limb preservation
This is probably the strongest near-term opportunity. Mauritania’s diabetes prevalence is not as high as some North African markets, but the undiagnosed rate is extremely high, which may increase the risk of late presentation and complications. That supports a strong case for preventive foot care, custom insoles, offloading, and protective footwear.
Basic orthotics and mobility support
Because Mauritania remains a lower-middle-income market with likely access constraints, practical orthoses and mobility devices may have more relevance than highly specialised premium devices. WHO’s assistive technology framework is highly applicable here because it emphasizes function, independence, and daily participation rather than product prestige.
Rehabilitation and assistive technology integration
WHO EMRO’s rehabilitation guidance stresses that rehabilitation should be part of health systems, not treated as an afterthought. In Mauritania, that suggests opportunities for providers able to work with hospitals, NGOs, and development partners on functional care pathways rather than standalone device sales.
Longer-term market building
Mauritania is also the kind of market where early relationship-building can matter. Because the current market is relatively small and underdeveloped, companies and organizations that engage early on education, access, and clinician support may be better placed if service capacity grows over time. That is a strategic inference based on the country’s development trajectory and current service profile.
Main constraints
The constraints are significant. Mauritania’s market is small in absolute terms, health spending is modest, and the wider system still faces capacity gaps. WHO’s country overview highlights the breadth of basic health challenges still present, while the World Bank’s recent programme for Mauritania underscores that strengthening essential services and human capital remains a national priority. That means O&P growth is likely to be gradual and tied closely to broader health-system and development progress.
For O&P businesses, this means Mauritania is not likely to reward an off-the-shelf premium sales strategy. It is more likely to reward:
- value-based positioning
- durable products
- simple service models
- partnerships with health and development actors
- evidence that devices improve function while fitting real-world affordability constraints
That conclusion is an inference, but it follows directly from the country’s current health and economic profile.
Bottom line
Mauritania is a small but under-served rehabilitation and O&P market where the strongest opportunities lie in diabetic foot care, assistive technology access, practical orthotics, and durable mobility support. It is not a scale play like Egypt or Algeria, but it is a country where relatively modest improvements in access and service delivery could have meaningful functional impact. For IMEA CPO readers, Mauritania is best viewed as a market for practical, affordable, system-aware solutions rather than a market driven by high-end device demand alone.
